Page last updated: 2024-10-21

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Malnutrition

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Malnutrition in 1 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Malnutrition: An imbalanced nutritional status resulting from insufficient intake of nutrients to meet normal physiological requirement.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, X1
Wang, K1
Ren, XL1
Zhang, MD1
Wu, KN1
Wu, H1
Chu, ZW1
Liu, SS1
Jiang, XX1
Zhu, JH1
Wu, HM1

Other Studies

1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Malnutrition

ArticleYear
Zinc Deficiency Exacerbates Behavioral Impediments and Dopaminergic Neuron Degeneration in a Mouse Model of Parkinson Disease.
    The Journal of nutrition, 2023, Volume: 153, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Diet; Disease Models, Animal; Dopamine; Dopam

2023